MedEsthetics
SEPTEMBER 18, 2024
Generally, ingredients are screened on individual strains of bacteria but this does not account for the interaction between microorganisms. Evonik’s model co-cultivates 8-10 skin microbes to observe interactions, better supporting microbiome claims.
Salon Today
SEPTEMBER 18, 2024
Are you frustrated when clients snap a picture of your product in the salon, only to buy it elsewhere? Join the Beauty Retail Revolution and take your sales back!
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedEsthetics
SEPTEMBER 18, 2024
MERIT's new Great Skin Priming Moisturizer uses arctic microalgae to give skin eco-friendly, time-released hydration all day long.
Starpil Wax
SEPTEMBER 18, 2024
If you're new to waxing or deciding whether or not to give it a try, you might wonder about the best time to wax your armpits , or how to keep yourself hair-free without overdoing it. To get the most out of your waxing routine, it's helpful to understand when armpit hair grows and the stages of the hair growth cycle for best results. Table of Contents Understanding the Hair Growth Cycle When Does Underarm Hair Grow?
Lipgloss and Aftershave
SEPTEMBER 18, 2024
Winter Skincare Essentials: Nurturing the Microbiome and Skin Barrier with Expert Tips Face Reality will lead this informative session. As the seasons change, so should your skincare routine, but one thing remains constant: maintaining a healthy microbiome and strong skin barrier. Join licensed esthetician Kelsey Duque for an expert guide on keeping skin clear and healthy during colder months.
Mindbody
SEPTEMBER 18, 2024
Learn how to leverage local influencers and brand ambassadors to grow your business, reach more potential clients, and build your brand in an authentic way.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
Mindbody
SEPTEMBER 18, 2024
Learn how to leverage local influencers and brand ambassadors to grow your business, reach more potential clients, and build your brand in an authentic way.
Dermatology Times
SEPTEMBER 18, 2024
In a session at Maui Derm NP+PA Fall 2024, Julie Harper, MD, ran through 5 key takeaways for providers managing patients with acne, including where the new triple fixed-dose combination treatment falls in the treatment landscape.
The Dermatology Digest
SEPTEMBER 18, 2024
The American Society for Dermatologic Surgery Association (ASDSA), in conjunction with the American Academy of Dermatology Association (AADA), the National Council on Skin Cancer Prevention (NCSCP) and 21 other leading dermatologic associations and skin cancer prevention organizations, are calling on the U.S. Surgeon General to renew the Call to Action to Prevent Skin Cancer.
Dermatology Times
SEPTEMBER 18, 2024
In his signature Maui Derm NP+PA Fall 2024 session, Shapiro discusses the importance of acting quickly when confronted with a patient who has scarring alopecia.
The Dermatology Digest
SEPTEMBER 18, 2024
Organon is acquiring Dermavant Sciences Ltd. Dermavant’s novel product, tapinarof cream, 1% (Vtama) for the topical treatment of mild, moderate, and severe plaque psoriasis in adults, was approved by the U.S. Food and Drug Administration (FDA) in May 2022. The FDA is reviewing a Supplemental New Drug Application (sNDA) for tapinarof cream, 1% as a potential treatment for atopic dermatitis (AD) in adults and children two years of age and older, with Prescription Drug User Fee Act (“PDUFA”) actio
Dermatology Times
SEPTEMBER 18, 2024
From dupilumab to OX40s, Zirwas talked about the niche to all atopic dermatitis therapies to make the best decision with your patient.
Dermatology Times
SEPTEMBER 18, 2024
Del Rosso’s cases emphasized the importance of thorough patient evaluation and communication with other health care providers.
Dermatology Times
SEPTEMBER 18, 2024
In a session at Maui Derm NP+PA Fall, Zirwas talked about the newfound discoveries of causation within the AD space.
Dermatology Times
SEPTEMBER 18, 2024
Dermavant’s sNDA for tapinarof cream 1% for AD is still under review with the FDA.
Expert insights. Personalized for you.
78 
Let's personalize your content